skip to main content

Gitelman Syndrome Prognosis — ESENeph MCQ

Instant feedback + full explanation. One question, done properly.

EasyTubular DisordersGitelman Syndrome PrognosisESENeph

A 35-year-old man with Gitelman syndrome is prescribed potassium and magnesium supplements. He asks about long-term prognosis. What should he be told?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Gitelman syndrome has an excellent renal prognosis; ESKD is extremely rare; quality of life may be affected by symptoms

Gitelman syndrome has an excellent long-term renal prognosis. GFR is generally preserved throughout life, and progression to ESKD is extremely rare. However, quality of life can be significantly affected by symptoms (fatigue, muscle cramps, weakness, salt craving, chondrocalcinosis). Lifelong potassium and magnesium supplementation is required. NSAIDs (Indometacin) can help with potassium retention. The main morbidity is symptom burden, not renal failure.

Reference: Blanchard et al 2017 – Gitelman Syndrome Prognosis; ERA-EDTA Tubular Disorders